Evidence map›Paper›PMID 36503402›Full record

ArticleCell adhesion & migration2023

Dynamized ultra-low dilution of

Camille Fuselier, Eleonore Dufay, Alexandre Berquand, Christine Terryn, Arnaud Bonnomet, Michael Molinari, Laurent Martiny, Christophe Schneider

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell adhesion & migration, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. International journal of molecular sciences · 2025
    Article
  2. Review
  3. Ethyl acetate extract ofFrontiers in pharmacology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Camille FuselierCenter Armand-Frappier Santé Biotechnologie of the INRS, University of Quebec, Laval, Quebec, Canada.
Eleonore DufayCNRS UMR 7369 MEDyC, University of Reims Champagne-Ardenne, Reims, France.
Alexandre BerquandLRN EA 4682, University of Reims Champagne-Ardenne, Reims, France.
Christine TerrynPlatform PICT, University of Reims Champagne-Ardenne, Reims, France.
Arnaud BonnometPlatform PICT, University of Reims Champagne-Ardenne, Reims, France.
Michael MolinariInstitute of Chemistry & Biology of Membranes & Nano-objects, Bordeaux, France.
Laurent MartinyCNRS UMR 7369 MEDyC, University of Reims Champagne-Ardenne, Reims, France.
Christophe SchneiderCNRS UMR 7369 MEDyC, University of Reims Champagne-Ardenne, Reims, France.
Centre National de la Recherche Scientifique · FRUniversité de Reims Champagne-Ardenne · FRChimie et Biologie des Membranes et des Nanoobjects · FRInstitut National de la Recherche Scientifique · CALaboratoire de Recherche en Nanosciences

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous melanoma is a cancer with a very poor prognosis mainly because of metastatic dissemination and therefore a deregulation of cell migration. Current therapies can benefit from complementary medicines as supportive care in oncology. In our study, we show that a dynamized ultra-low dilution of

Indexed as

MelanomaRutaSkin NeoplasmsCell MembraneCutaneous Malignant MelanomaHumansPlant ExtractsPlant Extractscancerdynamized ultra-low dilutionMelanomamigrationplasma membrane

Identifiers

PMID36503402
PMCPMC9746621
OpenAlexW4311125624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.